EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

LV Structure and Function in HFrEF With and Without Peak-Flow-Triggered Adaptive Servo-Ventilation-Treated Sleep-Disordered Breathing

Shoichiro Yatsu, Anna Woo, Christian M Horvath, Tomoyuki Tobushi, Alexander G Logan, John S Floras, George Tomlinson, T Douglas Bradley, ADVENT-HF Investigators

JACC: Heart Failure · 2026

DOI: 10.1016/j.jchf.2025.02.016 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JACC: Heart Failure, 2026. Verfasst von Shoichiro Yatsu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sleep Research Laboratories of the University Health Network, Toronto Rehabilitation Institute (KITE) and Toronto General Hospital and University of …. Hauptthemen laut MEDLINE: Heart Failure, Ventricular Remodeling, Sleep Apnea Syndromes, Ventricular Dysfunction, Left. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Philips Respironics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sleep-disordered breathing (SDB), comprising obstructive sleep apnea (OSA) and central sleep apnea (CSA), could promote left ventricular (LV) remodeling and systolic dysfunction. OBJECTIVES: The authors tested the hypothesis, in the ADVENT-HF (Adaptive Servo-ventilation for Sleep-disordered Breathing in Patients with Heart Failure with Reduced Ejection Fraction) trial, that SDB is associated with reversible impairment of LV structure and function. METHODS: Participants underwent echocardiography (ejection fraction ≤45%) and polysomnography. They were classified as no-SDB (apnea-hypopnea index [AHI] 50% of events central). Those with SDB were randomized to a control group or to peak-flow-triggered adaptive servo-ventilation (ASVPF) to treat SDB and, in them, echocardiography was repeated 6 months later. RESULTS: Subjects with OSA (n = 543) had similar LV structure and function to those without SDB (n = 56). Subjects with CSA (n = 201) had greater LV mass index and lower LV ejection fraction than the other groups. LV volumes were higher in the CSA than in the OSA group (P < 0.05 for all). ASVPF abolished SDB, but had no significant effect, whether evaluated by allocation or adherence, 6 months post-randomization on LV structure or function for the entire cohort (n = 549), or either subgroup. CONCLUSIONS: Among patients with heart failure with reduced ejection fraction, those with OSA had similar LV structure and function to those without SDB. Patients with CSA had greater LV remodeling and systolic dysfunction than those with OSA or without SDB. Six months of SDB suppression of OSA and CSA by ASVPF had no impact on LV structure or function. (Adaptive Servo-ventilation for Sleep-disordered Breathing in Patients with Heart Failure with Reduced Ejection Fraction [ADVENT-HF]).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureVentricular RemodelingSleep Apnea SyndromesVentricular Dysfunction, LeftHeart VentriclesSleep Apnea, CentralVentricular Function, LeftSleep Apnea, ObstructiveHumansMaleFemaleMiddle AgedPolysomnographyEchocardiographyStroke VolumeAged

Stichwörter der Autor:innen

central sleep apneaechocardiographyleft ventricular remodelingobstructive sleep apnearandomized controlled clinical trial

Autor:innen und Institutionen

  • Sleep Research Laboratories of the University Health Network, Toronto Rehabilitation Institute (KITE) and Toronto General Hospital and University of Toronto, Toronto, Canada; Department of Medicine, University Health Ne…
  • Department of Medicine, University Health Network and Sinai Health and University of Toronto, Toronto, Canada; Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.
  • Department of Medicine, University Health Network and Sinai Health and University of Toronto, Toronto, Canada; Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada; Toronto General Hospital Res…
  • Department of Medicine, University Health Network and Sinai Health and University of Toronto, Toronto, Canada; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Ontario, Canada.
  • Toronto General Hospital Research Institute, Toronto, Ontario, Canada.

Förderung

  • Philips Respironics

Zitieren

APA

Yatsu, S., Woo, A., Horvath, C. M., Tobushi, T., Logan, A. G., Floras, J. S., Tomlinson, G., Bradley, T. D., & ADVENT-HF Investigators (2026). LV Structure and Function in HFrEF With and Without Peak-Flow-Triggered Adaptive Servo-Ventilation-Treated Sleep-Disordered Breathing. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2025.02.016

Vancouver

Yatsu S, Woo A, Horvath CM, Tobushi T, Logan AG, Floras JS, et al. LV Structure and Function in HFrEF With and Without Peak-Flow-Triggered Adaptive Servo-Ventilation-Treated Sleep-Disordered Breathing. JACC: Heart Failure. 2026. doi:10.1016/j.jchf.2025.02.016

BibTeX
@article{Yatsu2026,
  author = {Yatsu, Shoichiro and Woo, Anna and Horvath, Christian M and Tobushi, Tomoyuki and Logan, Alexander G and Floras, John S and Tomlinson, George and Bradley, T Douglas and ADVENT-HF Investigators, ADVENT-HF Investigators},
  title = {LV Structure and Function in HFrEF With and Without Peak-Flow-Triggered Adaptive Servo-Ventilation-Treated Sleep-Disordered Breathing},
  journal = {JACC: Heart Failure},
  year = {2026},
  doi = {10.1016/j.jchf.2025.02.016}
}
Kostenlos starten →